Overview

Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of early corticosteroid discontinuation in liver transplant recipients more than 90 days post transplant, utilizing a combination of two drugs (tacrolimus and mycophenolate mofetil) for maintenance immunosuppressant therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Astellas Pharma Inc
Treatments:
Mycophenolate mofetil
Mycophenolic Acid
Prednisone
Tacrolimus